Publications by authors named "Daniel Keavy"

Claim this Profile
2
2-(N-Benzyl-N-phenylsulfonamido)alkyl amide derivatives as γ-secretase inhibitors.
Michael F Parker, Donna M Barten, Carl P Bergstrom, Joanne J Bronson, Jason A Corsa, Daniel J Keavy

Bioorg Med Chem Lett· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-(5-chloro-2-(hydroxymethyl)-N-alkyl-arylsulfonamides as gamma-secretase inhibitors.
Michael F Parker, Donna M Barten, Carl P Bergstrom, Joanne J Bronson, Jason A Corsa, Daniel J Keavy

Bioorg Med Chem Lett· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo metabolism of a gamma-secretase inhibitor BMS-299897 and generation of active metabolites in milligram quantities with a microbial bioreactor.
Donglu Zhang, Ronald Hanson, Vikram Roongta, Douglas D Dischino, Qi Gao, Daniel Keavy

Curr Drug Metab· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronobiotic activity of N-[2-(2,7-dimethoxyfluoren-9-yl)ethyl]-propanamide. Synthesis and melatonergic pharmacology of fluoren-9-ylethyl amides.
James R Epperson, Marc A Bruce, John D Catt, Jeffrey A Deskus, Donald B Hodges, Daniel J Keavy

Bioorg Med Chem· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indanyl piperazines as melatonergic MT2 selective agents.
Ronald J Mattson, John D Catt, Daniel Keavy, Charles P Sloan, James Epperson

Bioorg Med Chem Lett· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis